» Articles » PMID: 9665199

Establishment and Characterization of a Megakaryoblast Cell Line with Amplification of MLL

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 1998 Jul 17
PMID 9665199
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

A new cell line with megakaryoblastic features, designated UoC-M1, was established from the malignant cells of a 68-year-old patient with acute myeloid leukemia. The patient's leukemic cells reacted with alpha-naphthyl acetate esterase and acid phosphatase and expressed CD7, CD24, CD34, CD38, CD45, HLA-DR and CD61. Cytogenetic analysis of the patient's malignant cells (and of the UoC-M1 cells) showed a human, male hypodiploid karyotype with many chromosome rearrangements and marker chromosomes. Spectral karyotyping (SKY) analysis complemented the G-banded karyotyping and clarified several chromosomal translocations and identified the marker chromosomes. Fluorescence in situ hybridization (FISH) and SKY analysis demonstrated that one marker chromosome contained three segments of chromosome 9 interspersed with three segments of chromosome 11, as well as a portion of chromosome 19. FISH analysis with a probe for MLL revealed that the UoC-M1 cells contained four copies of the MLL gene. Southern blot analysis determined that the MLL gene had a germline profile while Northern and Western analyses showed that the MLL mRNAs and protein were of the appropriate sizes. This is the first report of amplification of the MLL gene which may be an additional mechanism of leukemogenesis or disease progression.

Citing Articles

Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research.

Skopek R, Palusinska M, Kaczor-Keller K, Pingwara R, Papierniak-Wygladala A, Schenk T Int J Mol Sci. 2023; 24(6).

PMID: 36982453 PMC: 10049680. DOI: 10.3390/ijms24065377.


Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.

Thiollier C, Lopez C, Gerby B, Ignacimouttou C, Poglio S, Duffourd Y J Exp Med. 2012; 209(11):2017-31.

PMID: 23045605 PMC: 3478932. DOI: 10.1084/jem.20121343.


Heat-shock protein expression in leukemia.

Sedlackova L, Spacek M, Holler E, Imryskova Z, Hromadnikova I Tumour Biol. 2010; 32(1):33-44.

PMID: 20694586 DOI: 10.1007/s13277-010-0088-7.


The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expression.

Xia Z, Popovic R, Chen J, Theisler C, Stuart T, Santillan D Proc Natl Acad Sci U S A. 2005; 102(39):14028-33.

PMID: 16169901 PMC: 1236570. DOI: 10.1073/pnas.0506464102.


Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia.

Qian Z, Fernald A, Godley L, Larson R, Le Beau M Proc Natl Acad Sci U S A. 2002; 99(23):14925-30.

PMID: 12417757 PMC: 137521. DOI: 10.1073/pnas.222491799.